1. Home
  2. IGC vs MGN Comparison

IGC vs MGN Comparison

Compare IGC & MGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IGC
  • MGN
  • Stock Information
  • Founded
  • IGC 2005
  • MGN 2020
  • Country
  • IGC United States
  • MGN Malaysia
  • Employees
  • IGC N/A
  • MGN N/A
  • Industry
  • IGC Biotechnology: Pharmaceutical Preparations
  • MGN
  • Sector
  • IGC Health Care
  • MGN
  • Exchange
  • IGC Nasdaq
  • MGN Nasdaq
  • Market Cap
  • IGC 39.8M
  • MGN 43.0M
  • IPO Year
  • IGC N/A
  • MGN 2025
  • Fundamental
  • Price
  • IGC $0.40
  • MGN $1.66
  • Analyst Decision
  • IGC Strong Buy
  • MGN
  • Analyst Count
  • IGC 2
  • MGN 0
  • Target Price
  • IGC $4.00
  • MGN N/A
  • AVG Volume (30 Days)
  • IGC 886.9K
  • MGN 713.5K
  • Earning Date
  • IGC 11-14-2025
  • MGN 11-11-2025
  • Dividend Yield
  • IGC N/A
  • MGN N/A
  • EPS Growth
  • IGC N/A
  • MGN N/A
  • EPS
  • IGC N/A
  • MGN 0.07
  • Revenue
  • IGC $1,327,000.00
  • MGN $13,484,571.00
  • Revenue This Year
  • IGC $3.54
  • MGN N/A
  • Revenue Next Year
  • IGC $15.12
  • MGN N/A
  • P/E Ratio
  • IGC N/A
  • MGN $24.67
  • Revenue Growth
  • IGC 24.95
  • MGN N/A
  • 52 Week Low
  • IGC $0.25
  • MGN $1.60
  • 52 Week High
  • IGC $0.50
  • MGN $8.63
  • Technical
  • Relative Strength Index (RSI)
  • IGC 46.88
  • MGN N/A
  • Support Level
  • IGC $0.36
  • MGN N/A
  • Resistance Level
  • IGC $0.43
  • MGN N/A
  • Average True Range (ATR)
  • IGC 0.02
  • MGN 0.00
  • MACD
  • IGC 0.00
  • MGN 0.00
  • Stochastic Oscillator
  • IGC 46.64
  • MGN 0.00

About IGC IGC Pharma Inc.

IGC Pharma Inc develops cannabinoid-based formulations for treating diseases and conditions, including, but not limited to, Alzheimer's disease, period cramps, premenstrual syndrome, and chronic pain. The company has investigational drug assets targeting Alzheimer's disease, IGC-AD1, IGC-M3, IGC-1C, and TGR-63, which have demonstrated in Alzheimer's cell lines the potential to be effective in suppressing or ameliorating key hallmarks of Alzheimer's disease, such as plaques or tangles.

About MGN Megan Holdings Limited Ordinary Shares

Megan Holdings Ltd is principally engaged in the development, construction and maintenance of aquaculture farms and related works. Its operations are based in Malaysia. The company's operating segments include: Aquaculture and agriculture; Industrial solutions; and Investment in marketable securities. It derives maximum revenue from Aquaculture and agriculture, which involves development, construction, and maintenance of aquaculture and agriculture farms and related works.

Share on Social Networks: